Targeting PRMT5 with indole-based arylsulfonylhydrazides: a novel epigenetic strategy for the treatment of acute and chronic leukemia.
Аннотация
Hematological malignancies, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL), are characterized by extensive epigenetic dysregulation. Protein arginine methyltransferase 5 (PRMT5) is an important epigenetic regulator that contributes to leukemic stem-cell maintenance, impaired differentiation, therapeutic resistance, and immune evasion. Although PRMT5 is a promising therapeutic target, no PRMT5 inhibitor has yet been approved by the FDA. In this study, we investigated a mini-library of indole-based arylsulfonylhydrazide derivatives previously synthesized by Azam et al. Their reported 1H and 13C NMR data were used to confirm the structural consistency of the scaffold. The compounds were then evaluated as potential PRMT5-associated anti-leukemic agents using molecular docking, molecular dynamics simulation, MM-GBSA analysis, and in vitro biological assays. Docking at the SAM-binding pocket of PRMT5 identified compound 5f as the lead analogue, with the best Glide docking score of -10.2 kcal/mol. Compound 5f formed key interactions with Ser310, Glu435/Glu444, Phe327, Phe577, Phe580, and Ser578, including hydrogen bonding, π-stacking, water-bridge interactions, and halogen-π stabilization. Molecular dynamics simulations over 500 ns supported stable ligand binding, and MM-GBSA analysis showed a favorable binding free energy (ΔG_bind = -96.49 kcal/mol). Compound 5f also showed strong cytotoxic activity against leukemia cell lines, with 48 h IC50 values of 0.85 µM in HL-60 cells, 0.95 µM in NALM-6 cells, and 1.20 µM in K562 cells. Clonogenic assays showed reduced colony formation, and fluorescence microscopy indicated apoptotic nuclear fragmentation and membrane permeabilization. Western blot analysis showed reduced PRMT5 expression and decreased symmetric dimethylation of histone H4 at arginine 3 (H4R3me2s), accompanied by increased p21, p53, and cleaved caspase-3 expression. Overall, these findings suggest that indole-based arylsulfonylhydrazides may serve as promising PRMT5-associated epigenetic lead compounds for further development against acute and chronic leukemia.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.